| # | Title | Journal | Year | Citations |
|---|
| 1 | Irritable bowel syndrome | Nature Reviews Disease Primers | 2016 | 674 |
| 2 | Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis | American Journal of Gastroenterology | 2014 | 595 |
| 3 | Microbiota-Brain-Gut Axis and Neurodegenerative Diseases | Current Neurology and Neuroscience Reports | 2017 | 513 |
| 4 | American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation | American Journal of Gastroenterology | 2014 | 503 |
| 5 | The microbiome and inflammatory bowel disease | Journal of Allergy and Clinical Immunology | 2020 | 454 |
| 6 | Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis | American Journal of Gastroenterology | 2014 | 335 |
| 7 | A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPS Diet in Treating Symptoms of Irritable Bowel Syndrome | American Journal of Gastroenterology | 2018 | 269 |
| 8 | American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome | American Journal of Gastroenterology | 2018 | 262 |
| 9 | The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis | American Journal of Gastroenterology | 2014 | 258 |
| 10 | The Intestinal Microenvironment and Functional Gastrointestinal Disorders | Gastroenterology | 2016 | 243 |
| 11 | Prebiotics and Probiotics in Digestive Health | Clinical Gastroenterology and Hepatology | 2019 | 215 |
| 12 | Probiotics in Inflammatory Bowel Disease | Gastroenterology Clinics of North America | 2017 | 131 |
| 13 | Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis | Gut | 2020 | 122 |
| 14 | Gut bacteria in health and disease | Gastroenterology and Hepatology | 2013 | 120 |
| 15 | Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis | Gastroenterology | 2018 | 119 |
| 16 | Leaky gut – concept or clinical entity? | Current Opinion in Gastroenterology | 2016 | 100 |
| 17 | Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet? | Nature Reviews Gastroenterology and Hepatology | 2017 | 96 |
| 18 | Efficacy and Safety of Digital Single-Operator Cholangioscopy for Difficult Biliary Stones | Clinical Gastroenterology and Hepatology | 2018 | 89 |
| 19 | The Spectrum of Small Intestinal Bacterial Overgrowth (SIBO) | Current Gastroenterology Reports | 2019 | 79 |
| 20 | Small intestinal bacterial overgrowth | Current Opinion in Gastroenterology | 2014 | 77 |
| 21 | The Gut-Brain Axis and the Microbiome: Clues to Pathophysiology and Opportunities for Novel Management Strategies in Irritable Bowel Syndrome (IBS) | Journal of Clinical Medicine | 2018 | 73 |
| 22 | Nonsteroidal Anti-inflammatory Drugs, Proton Pump Inhibitors, and Gastrointestinal Injury: Contrasting Interactions in the Stomach and Small Intestine | Mayo Clinic Proceedings | 2014 | 70 |
| 23 | Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye? | Therapeutic Advances in Gastroenterology | 2016 | 63 |
| 24 | Engineered biomimetic nanovesicles show intrinsic anti-inflammatory properties for the treatment of inflammatory bowel diseases | Nanoscale | 2017 | 57 |
| 25 | An update on prucalopride in the treatment of chronic constipation | Therapeutic Advances in Gastroenterology | 2017 | 54 |
| 26 | The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review | Clinical and Translational Gastroenterology | 2015 | 48 |
| 27 | A four‐country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders | Neurogastroenterology and Motility | 2014 | 41 |
| 28 | Prokinetics in the Management of Functional Gastrointestinal Disorders | Journal of Neurogastroenterology and Motility | 2015 | 41 |
| 29 | Immune response in irritable bowel syndrome: A systematic review of systemic and mucosal inflammatory mediators | Journal of Digestive Diseases | 2016 | 41 |
| 30 | Gastrointestinal motility problems in critical care: A clinical perspective | Journal of Digestive Diseases | 2014 | 39 |
| 31 | Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity | BMJ Open Gastroenterology | 2022 | 39 |
| 32 | The Gut Microbiota and Nonalcoholic Fatty Liver Disease | Seminars in Liver Disease | 2015 | 38 |
| 33 | Constipation and the Microbiome: Lumen Versus Mucosa! | Gastroenterology | 2016 | 37 |
| 34 | Recent advances in modulating the microbiome | F1000Research | 2020 | 36 |
| 35 | Definition, Pathogenesis, and Management of That Cursed Dyspepsia | Clinical Gastroenterology and Hepatology | 2018 | 35 |
| 36 | Prokinetics in the Management of Functional Gastrointestinal Disorders | Current Gastroenterology Reports | 2017 | 33 |
| 37 | Small Intestinal Bacterial Overgrowth—Pathophysiology and Its Implications for Definition and Management | Gastroenterology | 2022 | 33 |
| 38 | Nutraceuticals as modulators of gut microbiota: Role in therapy | British Journal of Pharmacology | 2020 | 28 |
| 39 | Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease | Crohn's & Colitis 360 | 2022 | 28 |
| 40 | The role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal disease | Therapeutic Advances in Gastroenterology | 2016 | 26 |
| 41 | The role of the microbiome and the use of probiotics in gastrointestinal disorders in adults in the Asia‐Pacific region ‐ background and recommendations of a regional consensus meeting | Journal of Gastroenterology and Hepatology (Australia) | 2018 | 24 |
| 42 | Neurogenic Bowel Dysfunction in Patients with Neurogenic Bladder | Current Bladder Dysfunction Reports | 2016 | 20 |
| 43 | Radiation Exposure in Gastroenterology: Improving Patient and Staff Protection | American Journal of Gastroenterology | 2014 | 18 |
| 44 | Other Forms of Gastroparesis | Gastroenterology Clinics of North America | 2015 | 18 |
| 45 | The diagnosis of small intestinal bacterial overgrowth: Two steps forward, one step backwards? | Neurogastroenterology and Motility | 2018 | 16 |
| 46 | Small Intestinal Bacterial Overgrowth | Gastroenterology Clinics of North America | 2021 | 14 |
| 47 | The Microbiome and the Liver: The Basics | Seminars in Liver Disease | 2016 | 13 |
| 48 | Primary Biliary Cirrhosis and the Microbiome | Seminars in Liver Disease | 2016 | 13 |
| 49 | Advancing treatment options for chronic idiopathic constipation | Expert Opinion on Pharmacotherapy | 2016 | 13 |
| 50 | Randomised clinical trial: daily pantoprazole magnesium 40 mg vs. esomeprazole 40 mg for gastro-oesophageal reflux disease, assessed by endoscopy and symptoms | Alimentary Pharmacology and Therapeutics | 2014 | 12 |
